KR102373207B1 - 스테아리돈산 및 올리브 오일을 포함하는 식용 지질 조성물 - Google Patents

스테아리돈산 및 올리브 오일을 포함하는 식용 지질 조성물 Download PDF

Info

Publication number
KR102373207B1
KR102373207B1 KR1020167010874A KR20167010874A KR102373207B1 KR 102373207 B1 KR102373207 B1 KR 102373207B1 KR 1020167010874 A KR1020167010874 A KR 1020167010874A KR 20167010874 A KR20167010874 A KR 20167010874A KR 102373207 B1 KR102373207 B1 KR 102373207B1
Authority
KR
South Korea
Prior art keywords
sda
oil
olive oil
epa
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020167010874A
Other languages
English (en)
Korean (ko)
Other versions
KR20160065903A (ko
Inventor
하르멘 호프스트라
오르잔 사엘
올라 에이디
린다 크리스틴 사가
Original Assignee
친치노 에이비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 친치노 에이비 filed Critical 친치노 에이비
Publication of KR20160065903A publication Critical patent/KR20160065903A/ko
Application granted granted Critical
Publication of KR102373207B1 publication Critical patent/KR102373207B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
KR1020167010874A 2013-10-07 2014-10-07 스테아리돈산 및 올리브 오일을 포함하는 식용 지질 조성물 Active KR102373207B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13187560 2013-10-07
EP13187560.1 2013-10-07
PCT/EP2014/071418 WO2015052171A1 (en) 2013-10-07 2014-10-07 Edible lipid composition comprising stearidonic acid and olive oil

Publications (2)

Publication Number Publication Date
KR20160065903A KR20160065903A (ko) 2016-06-09
KR102373207B1 true KR102373207B1 (ko) 2022-03-11

Family

ID=49301375

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167010874A Active KR102373207B1 (ko) 2013-10-07 2014-10-07 스테아리돈산 및 올리브 오일을 포함하는 식용 지질 조성물

Country Status (15)

Country Link
US (1) US20160227808A1 (enExample)
EP (1) EP3054777B1 (enExample)
JP (1) JP6506746B2 (enExample)
KR (1) KR102373207B1 (enExample)
CN (1) CN105705025B (enExample)
AU (1) AU2014333878B2 (enExample)
CA (1) CA2924265C (enExample)
DK (1) DK3054777T3 (enExample)
EA (1) EA028641B1 (enExample)
ES (1) ES2672313T3 (enExample)
HU (1) HUE037991T2 (enExample)
LT (1) LT3054777T (enExample)
NO (1) NO3054777T3 (enExample)
PL (1) PL3054777T3 (enExample)
WO (1) WO2015052171A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10846257B2 (en) 2014-04-01 2020-11-24 Endance Technology Limited Intelligent load balancing and high speed intelligent network recorders
CN108402466A (zh) * 2017-02-10 2018-08-17 台湾原生药用植物股份有限公司 含不饱和脂肪酸的素食组合物
JP6901274B2 (ja) * 2017-02-14 2021-07-14 株式会社ファンケル ω３系脂肪酸吸収促進用組成物
US11638440B2 (en) * 2017-02-28 2023-05-02 Cg-Bio Genomics, Inc. Healthful supplement food
US20240091110A1 (en) * 2019-10-07 2024-03-21 Colgate-Palmolive Company Oral Care Compositions and Methods of Use
KR102748655B1 (ko) * 2021-12-20 2025-01-02 씨제이제일제당 (주) 스쿠알렌 및 토코페롤을 포함하는 유지의 색가 안정용 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000104092A (ja) * 1998-09-29 2000-04-11 Nof Corp 血清脂質改善油脂組成物
US20070207223A1 (en) * 2006-03-03 2007-09-06 Dirienzo Maureen A Means for improving cardiovascular health

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2150741A1 (en) * 1994-06-17 1995-12-18 Susan Trimbo Pediatric lipid emulsion
ES2202454T3 (es) * 1995-07-04 2004-04-01 Suntory Limited Uso de un agente equilibrante para acidos grasos insaturados omega-3 y omega-6.
JP3466014B2 (ja) * 1995-12-25 2003-11-10 交洋ファインケミカル株式会社 植物性スクワラン濃縮物の製造方法
JP2007056181A (ja) * 2005-08-26 2007-03-08 Toyo Olive Co Ltd 機能性オリーブ油、その製造方法およびその用途
JP4904751B2 (ja) * 2005-09-14 2012-03-28 株式会社カネカ 生体内ｄｈａ合成促進剤
ES2289897B1 (es) * 2005-11-08 2008-12-16 Laboratorios Belmac, S.A. Composicion para administracion transdermica de agentes fisiologicamente activos.
NZ578166A (en) * 2007-01-03 2012-04-27 Monsanto Technology Llc Food compositions incorporating stearidonic acid
US20090099261A1 (en) * 2007-09-25 2009-04-16 Isi Brands Inc. Omega-3 mixtures
EP2448431A4 (en) * 2009-06-30 2014-12-31 Solae Llc BARRIER COMPOSITIONS AND OVEN-COOKED FOOD ENRICHED WITH OMEGA-3 FATTY ACID
FR2948025B1 (fr) * 2009-07-15 2013-01-11 Univ Grenoble 1 Composition comprenant un polyphenol et un acide gras omega-3
IN2012DN00563A (enExample) * 2009-07-15 2015-06-12 Solae Llc
US8372465B2 (en) * 2010-02-17 2013-02-12 Bunge Oils, Inc. Oil compositions of stearidonic acid
AU2012100994A4 (en) * 2012-06-30 2012-07-26 Hinson, Brian Mr Hempseed/olive oil and waste blending

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000104092A (ja) * 1998-09-29 2000-04-11 Nof Corp 血清脂質改善油脂組成物
US20070207223A1 (en) * 2006-03-03 2007-09-06 Dirienzo Maureen A Means for improving cardiovascular health

Also Published As

Publication number Publication date
EA028641B1 (ru) 2017-12-29
CN105705025B (zh) 2020-06-23
EP3054777B1 (en) 2018-03-07
HUE037991T2 (hu) 2018-09-28
PL3054777T3 (pl) 2018-10-31
KR20160065903A (ko) 2016-06-09
CA2924265A1 (en) 2015-04-16
NO3054777T3 (enExample) 2018-08-04
US20160227808A1 (en) 2016-08-11
EA201690692A1 (ru) 2016-07-29
WO2015052171A1 (en) 2015-04-16
LT3054777T (lt) 2018-07-10
CA2924265C (en) 2019-12-24
AU2014333878A2 (en) 2016-04-21
AU2014333878A1 (en) 2016-04-14
CN105705025A (zh) 2016-06-22
AU2014333878B2 (en) 2017-12-07
ES2672313T3 (es) 2018-06-13
JP6506746B2 (ja) 2019-04-24
DK3054777T3 (en) 2018-06-14
EP3054777A1 (en) 2016-08-17
JP2016533716A (ja) 2016-11-04

Similar Documents

Publication Publication Date Title
CA2694054C (en) Omega-3 fatty acid fortified composition
KR101503970B1 (ko) 오메가-3 풍부화된 비경구 영양 수중-어유 에멀전
Carandang Health benefits of virgin coconut oil
CA2924265C (en) Edible lipid composition comprising stearidonic acid and olive oil
US9301536B2 (en) Antioxidant composition for marine oils comprising tocopherol, rosemary extract, ascorbic acid and green tea extract
ES2351141B1 (es) Aceites funcionales a base de aceite de oliva.
Asif Chemical characteristics and nutritional potentials of unsaturated fatty acids
US8691293B2 (en) Low inflammatory blended oils
US20120219647A1 (en) Antioxidant composition
CA3069902A1 (en) Compositions comprising thymoquinone and omega-3 fatty acids
US20110236560A1 (en) Food supplementation with phenolic antioxidants in vinegar
CN107105695A (zh) 具有增强的抗氧化性的海洋卵磷脂制剂
Šarolić et al. Virgin olive oil and nutrition
KR20140116482A (ko) Dha 및 epa를 포함하는 유기 유화액
ES2413497B1 (es) Composición con alto contenido en Omega 3, Omega 6 y Omega 9
Suroowan et al. Olive and olive oil: a one stop herbal solution for the prophylaxis and management of cardiovascular disorders
HK1227637B (en) Edible lipid composition comprising stearidonic acid and olive oil
HK1227637A1 (en) Edible lipid composition comprising stearidonic acid and olive oil
JP5735576B2 (ja) コエンザイムｑ１０を含有する組成物
WO2012145119A2 (en) Low inflammatory blended oils
Shahidi et al. Dietary Lipid Supplements
KR20160041827A (ko) 혼합 견과유 조성물
RU2211043C2 (ru) Композиция для приготовления лекарственных форм и обогащения продуктов питания, способствующая коррекции нарушений липидного обмена, профилактики и лечения атеросклероза
Casanova Vallvé Modulation of muscle energy metabolism by bioactive compounds
CN112867486A (zh) 表现出增强的氧化稳定性的组合物

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 4